Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
98 participants
INTERVENTIONAL
2022-01-26
2022-07-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints
NCT06946017
Protein and Exercise-Induced Gastrointestinal Symptoms
NCT05855174
Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults
NCT02217579
The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites
NCT06677333
Effects of Increased, Egg-Based Protein Intake on Muscle Composition,
NCT01396915
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Question 1: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber affect the self-reported digestive comfort compared to a 3-week baseline period? And additionally, will the quality of life (self-reported general well-being and states of mood) change with the use of this type of product?
Question 2: Does the 3-week supplementation of a fermented dairy protein with prebiotic fiber show an alteration in gut microbiota in comparison to a 3-week baseline period, while dietary intake remains unaffected?
Question 3: How is the 3-week supplementation of a fermented dairy protein with prebiotic fiber experienced by the participants (taste and concept liking)?
Question 4: Is there a difference in baseline gut microbiota between athletes with and athletes without self-reported GI complaints.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single group
During a 3-week baseline period, participants with self-reported GI complaints consume their own protein supplement that they use for recovery purposes after exercise, followed by a 3-week intervention period in which they maintain usage of their own product, but replace a part of this product with a fermented dairy protein with prebiotic fiber. An additional reference group of athletes without self-reported GI complaints will also be followed during a 3-week period in which they consume their own protein supplement that they use for recovery purposes after exercise.
fermented dairy protein with prebiotic fiber
During the intervention period, the participant will consume a new product and will reduce the amount of protein in their normal diet reflecting the protein content of the new product.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
fermented dairy protein with prebiotic fiber
During the intervention period, the participant will consume a new product and will reduce the amount of protein in their normal diet reflecting the protein content of the new product.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Women/Men aged between 18-35 years
* Serious athletes (exercise at least 3 x per week)
* With or without GI tract issues due to sport or protein/diet intake
* 18.5 ≤ BMI ≤ 40 kg/m2
* No physical limitations (i.e. able to perform all activities associated with daily living in an independent manner).
* Use of a protein supplement or sports food after at least one training per day 3 x per week
* Willing to slightly increase their protein supplement intake during the intervention phase for 21 consecutive days
* Stable weight during the last 4 weeks, without a focus on body weight reduction through limiting caloric intake
* Written informed consent
Exclusion Criteria
* Smoking
* Self-reported cow's milk protein allergy
* Clinical lactose intolerance
* Clinical milk protein allergy
* House dust mite allergy
* Diagnosed GI tract disorders or diseases
* Musculoskeletal disorders
* Metabolic disorders (such as diabetes)
* Use of any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescribed acne medications).
* Chronic use of gastric acid-suppressing medication or anti-coagulants
* Use of antibiotics or anti-inflammatory medication the past 2 weeks
* Blood donation in the past 2 months
* Pregnant/lactating women
* Athletes should not aim to lose body weight by reducing energy intake during the study
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
FrieslandCampina
INDUSTRY
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Floris Wardenaar, PhD
Role: PRINCIPAL_INVESTIGATOR
Arizona State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona State University
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00014399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.